News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,730 Results
Type
Article (43050)
Company Profile (437)
Press Release (674243)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (209196)
Career Advice (2067)
Deals (36114)
Drug Delivery (104)
Drug Development (83721)
Employer Resources (173)
FDA (16507)
Job Trends (15174)
News (353666)
Policy (33218)
Tag
Academia (2658)
Accelerated approval (6)
Adcomms (25)
Allergies (87)
Alliances (51109)
ALS (96)
Alzheimer's disease (1435)
Antibody-drug conjugate (ADC) (144)
Approvals (16490)
Artificial intelligence (276)
Autoimmune disease (26)
Automation (16)
Bankruptcy (374)
Best Places to Work (11878)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (331)
Bladder cancer (83)
Brain cancer (27)
Breast cancer (292)
Cancer (2351)
Cardiovascular disease (191)
Career advice (1729)
Career pathing (30)
CAR-T (161)
Cell therapy (452)
Cervical cancer (20)
Clinical research (67921)
Collaboration (891)
Company closure (1)
Compensation (562)
Complete response letters (26)
COVID-19 (2652)
CRISPR (46)
C-suite (264)
Cystic fibrosis (105)
Data (2290)
Decentralized trials (2)
Denatured (28)
Depression (52)
Diabetes (283)
Diagnostics (6483)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (110)
Drug shortages (26)
Duchenne muscular dystrophy (102)
Earnings (88065)
Editorial (41)
Employer branding (21)
Employer resources (147)
Events (116466)
Executive appointments (758)
FDA (17835)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (796)
Gene editing (119)
Generative AI (21)
Gene therapy (334)
GLP-1 (751)
Government (4534)
Grass and pollen (4)
Guidances (95)
Healthcare (19221)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (134)
Indications (30)
Infectious disease (2799)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (99)
Interviews (325)
IPO (16815)
IRA (44)
Job creations (3746)
Job search strategy (1467)
Kidney cancer (10)
Labor market (38)
Layoffs (508)
Leadership (18)
Legal (8019)
Liver cancer (77)
Lung cancer (331)
Lymphoma (157)
Machine learning (8)
Management (58)
Manufacturing (323)
MASH (72)
Medical device (13594)
Medtech (13599)
Mergers & acquisitions (19846)
Metabolic disorders (735)
Multiple sclerosis (82)
NASH (19)
Neurodegenerative disease (105)
Neuropsychiatric disorders (33)
Neuroscience (2015)
NextGen: Class of 2025 (6798)
Non-profit (4565)
Now hiring (39)
Obesity (391)
Opinion (226)
Ovarian cancer (78)
Pain (95)
Pancreatic cancer (87)
Parkinson's disease (155)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (47)
People (58869)
Pharmaceutical (86)
Pharmacy benefit managers (21)
Phase I (21349)
Phase II (29976)
Phase III (22162)
Pipeline (1286)
Policy (153)
Postmarket research (2605)
Preclinical (9167)
Press Release (67)
Prostate cancer (111)
Psychedelics (37)
Radiopharmaceuticals (265)
Rare diseases (409)
Real estate (6043)
Recruiting (66)
Regulatory (22857)
Reports (46)
Research institute (2424)
Resumes & cover letters (355)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (79)
Series A (140)
Series B (92)
Service/supplier (11)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (153)
Sponsored (30)
Startups (3780)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (43)
The Weekly (50)
Vaccines (716)
Venture capitalists (43)
Weight loss (256)
Women's health (37)
Worklife (18)
Date
Today (166)
Last 7 days (802)
Last 30 days (2883)
Last 365 days (33922)
2025 (11504)
2024 (36464)
2023 (41114)
2022 (52362)
2021 (56840)
2020 (55036)
2019 (47620)
2018 (35826)
2017 (33281)
2016 (32554)
2015 (38543)
2014 (32294)
2013 (27243)
2012 (29331)
2011 (29977)
2010 (28103)
Location
Africa (747)
Alabama (58)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (39472)
Australia (6561)
California (6394)
Canada (2054)
China (544)
Colorado (276)
Connecticut (295)
Delaware (155)
Europe (86522)
Florida (925)
Georgia (208)
Idaho (58)
Illinois (568)
India (25)
Indiana (318)
Iowa (12)
Japan (169)
Kansas (107)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (932)
Massachusetts (4857)
Michigan (223)
Minnesota (404)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (64)
New Hampshire (67)
New Jersey (1793)
New Mexico (30)
New York (1792)
North Carolina (1050)
North Dakota (8)
Northern California (2778)
Ohio (210)
Oklahoma (14)
Oregon (38)
Pennsylvania (1419)
Puerto Rico (12)
Rhode Island (34)
South America (1128)
South Carolina (24)
South Dakota (1)
Southern California (2393)
Tennessee (102)
Texas (948)
United States (24173)
Utah (189)
Virginia (154)
Washington D.C. (65)
Washington State (583)
West Virginia (3)
Wisconsin (65)
717,730 Results for "x biotix therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PRECISIO BIOTIX THERAPEUTICS ANNOUNCES COLLABORATION WITH MAYO CLINIC
Precisio Biotix Therapeutics (“Precisio”) today announced it has entered into an agreement with Mayo Clinic.
March 14, 2024
·
3 min read
Deals
Precisio Biotix Therapeutics Acquires London-Headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists
Precisio Biotix Therapeutics announced the acquisition of CC Bio, creator of the ZEUS anti-bacterial lysin platform.
March 1, 2024
·
4 min read
Business
PRECISIO BIOTIX THERAPEUTICS EXPANDS THE US MANAGEMENT TEAM WITH THE HIRING OF DR. RAYMOND SCHUCH
Precisio Biotix Therapeutics (“Precisio”) today announced the hiring of Dr. Raymond (Ray) Schuch as Vice President, Director of US Operations.
January 23, 2024
·
2 min read
BioCapital
PRECISIO BIOTIX TO PRESENT AT BIOTECH SHOWCASE™ 2024 and BFC GLOBAL HEALTHCARE CONFERENCE
Precisio Biotix today announced that it is presenting at both the BFC Global Healthcare Conference and Biotech Showcase™ 2024.
January 5, 2024
·
1 min read
Press Releases
Myomo Launches the MyoPro® 2x
April 30, 2025
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Genetown
X-Biotix Therapeutics Announces Change in Corporate Strategy
X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of first-in-class antibiotic compounds targeting multi-drug-resistant Gram-negative pathogens, announced today a change in its strategy, which will include suspension of its current antibacterial research efforts.
April 26, 2021
·
4 min read
Press Releases
The NIMML Institute and NImmune Biopharma Showcase How the TITAN-X A.I. Platform has Accelerated Therapeutic Development in the Annual Review of Biomedical Data Science
April 21, 2025
·
6 min read
Press Releases
X4 Pharmaceuticals Announces Reverse Stock Split
April 24, 2025
·
6 min read
Press Releases
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
April 16, 2025
·
4 min read
1 of 71,773
Next
